On track for potential approval of bezuclastinib for GIST patients (PDUFA November 30) and NonAdvSM

Submission based on results of APEX pivotal trial which demonstrated bezuclastinib objective respons

Cogent Biosciences is positioned to build a niche KIT-mutant franchise, leveraging bezuclastinib acr

-  JAK2 V671F poster presentation showcases potential best-in-class properties, including improved s

-- Bezuclastinib demonstrated rapid and deep clinical benefit in AdvSM patients resulting in an upda

Bezuclastinib combination is first treatment ever to demonstrate statistically significant advantage

NDA acceptance with Priority Review builds upon previous assignment of Breakthrough Therapy Designat

WALTHAM, Mass. and BOULDER, Colo.

WALTHAM, Mass. and BOULDER, Colo., May 12, 2026 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq

- Planning for dual launches of bezuclastinib in Systemic Mastocytosis and Gastrointestinal Stromal

WALTHAM, Mass. and BOULDER, Colo.

– Updated presentation on Cogent's potent pan-KRAS(ON) inhibitor, CGT1263, showcasing its selectivit

Cogent Biosciences, Inc. maintains a Buy rating as bezuclastinib demonstrates blockbuster potential

Cogent Biosciences (NASDAQ: COGT - Get Free Report) and GT Biopharma (NASDAQ: GTBP - Get Free Report

WALTHAM, Mass. and BOULDER, Colo., April 01, 2026 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasd

UBS analysts have outlined a set of high-conviction healthcare ideas where they believed the market

RTW Investments added 4,124,755 Cogent Biosciences shares in the fourth quarter; the estimated trade

Kynam Capital sold 1,720,949 shares of Cogent Biosciences in the fourth quarter; the estimated trans

Boone Capital Management sold 945,042 shares of Cogent Biosciences in the fourth quarter. As a resul

FDA accepts Cogent Biosciences' NDA for bezuclastinib in NonAdvSM. PDUFA date set for Dec 30, 20

Shares of Sony Group Corporation (NYSE: SONY) fell during Wednesday’s session after the company rep

  On Tuesday, 647 companies set new 52-week lows.

Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) shares gained 124% to $0.3325. Mobiquity Tech

Gainers

Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company an

  On Wednesday, 807 companies reached new 52-week lows.

  During Tuesday's session, 454 stocks hit new 52-week lows.

    On Monday, 671 companies achieved new lows for the year.

Gainers Pioneer Power Solutions (NASDAQ: PPSI) shares climbed 205.7% to close at $4.80 on Tuesday

Gainers Pioneer Power Solutions (NASDAQ: PPSI) shares jumped 235.7% to $5.27. Comstock Holding C

Mid-Day Market Movers (ADAM, MPB, COGT, XFN)